zoledronic acid has been researched along with Orbital Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Han, LS; Weatherhead, RG | 1 |
| Herren, D; Kim, SJ; Kohanim, S; Umunakwe, OC | 1 |
| Kalin-Hajdu, E; Martin, TG; Narayan, R; Tan, M; Wong, SW | 1 |
| Chehade, LK; Curragh, D; Selva, D | 1 |
| Muruganandam, M; Sandhu, H | 1 |
| Procianoy, E; Procianoy, F | 1 |
| Jafer, AK; Yeo, J | 1 |
| Missotten, G; Verheezen, Y | 1 |
| Corretger, X; Fernandez, E; Molina, JJ; Navarro, M; Olver, JM; Ortiz-Perez, S; Sanchez-Dalmau, B | 1 |
1 review(s) available for zoledronic acid and Orbital Diseases
| Article | Year |
|---|---|
Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
Topics: Acute Disease; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Infusions, Intravenous; Orbital Diseases; Osteoporosis; Tomography, X-Ray Computed; Uveitis, Anterior; Zoledronic Acid | 2017 |
8 other study(ies) available for zoledronic acid and Orbital Diseases
| Article | Year |
|---|---|
Zoledronic acid associated orbital inflammation.
Topics: Bone Density Conservation Agents; Female; Glucocorticoids; Humans; Inflammation; Methylprednisolone; Middle Aged; Orbital Diseases; Osteoporosis, Postmenopausal; Tomography, X-Ray Computed; Zoledronic Acid | 2020 |
Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma.
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Inflammation; Male; Middle Aged; Multiple Myeloma; Orbital Diseases; Zoledronic Acid | 2019 |
Bisphosphonate-induced orbital inflammation: more common than once thought?
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Inflammation; Magnetic Resonance Imaging; Middle Aged; Orbital Diseases; Risedronic Acid; Tomography, X-Ray Computed; Zoledronic Acid | 2019 |
Orbital Inflammation Secondary to Zoledronic Acid, a Rare Presentation.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Glucocorticoids; Humans; Imidazoles; Magnetic Resonance Imaging; Orbital Diseases; Osteoporosis; Prednisone; Zoledronic Acid | 2016 |
Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.
Topics: Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Orbital Diseases; Osteoporosis, Postmenopausal; Prednisone; Tomography, X-Ray Computed; Zoledronic Acid | 2010 |
Zolendronate associated inflammatory orbital disease.
Topics: Bone Density Conservation Agents; Diabetic Foot; Diagnosis, Differential; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Orbital Diseases; Zoledronic Acid | 2010 |
Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma.
Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Conjunctivitis, Acute Hemorrhagic; Diphosphonates; Humans; Imidazoles; Inflammation; Male; Neoplasms, Second Primary; Neurofibroma; Orbital Diseases; Orbital Neoplasms; Prostatic Neoplasms; Zoledronic Acid | 2010 |
Two cases of drug-induced orbital inflammatory disease.
Topics: Aged; Bone Density Conservation Agents; Cataract Extraction; Cellulitis; Diagnosis, Differential; Diphosphonates; Female; Humans; Hyaluronoglucosaminidase; Imidazoles; Inflammation; Orbital Diseases; Paget Disease, Extramammary; Zoledronic Acid | 2011 |